UOTTAIMCU
TCRT icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Alaunos Therapeutics TCRT Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-16,691
Closed -$20.8M – 31
2015
Q4 		$20.8M Sell
16,691
-63,728
-79% -$105M 42.8% 1
2015
Q3 		$109M Hold
80,419
– – 53.44% 1
2015
Q2 		$145M Buy
80,419
+2,271
+3% +$3.53M 51.72% 1
2015
Q1 		$126M Buy
+78,148
New +$116M 49.23% 1

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s TCRT Position: Q1 2016 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Alaunos Therapeutics (TCRT) in Q1 2016, closing a stake of 16,691 shares — an estimated $20.8M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in TCRT in Q1 2015 and held it in 4 quarters. The position peaked at $145M in Q2 2015. 143 funds tracked by Wall St. Rank hold TCRT as of Q1 2016.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Alaunos Therapeutics position as of Q1 2016 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 16,691 Alaunos Therapeutics shares in Q1 2016, an estimated $20.8M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 4 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Alaunos Therapeutics position peaked at $145M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2016.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2016, filed 25 Apr 2016.